Former product innovator at BGI, Illumina, and Pacific Biosciences will spearhead technological development of breakthrough Molecular Cartography™ system MONHEIM AM RHEIN, Germany —  Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Frank Zhong, PhD, as Chief Technology Officer. In this role, Zhong will report to Co-founder and CEO Jason T. Gammack […]

Arul Chinnaiyan and Sten Linnarsson to bolster Rebus expertise and scientific direction SANTA CLARA, Calif. —  Rebus Biosystems Inc., (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that Drs. Arul Chinnaiyan, MD, PhD, and Sten Linnarsson, PhD, have been appointed to the Company’s […]

– Enabling solutions for biopharmaceutical development and production – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services. Fostering the development of the bioeconomy is one of the priority issues within Yokogawa’s sustainability goals, […]

Life science research distributor Nordic BioSite Group acquires Austrian Szabo Scandic to further expand geographical footprint – with ultimate goal of becoming an even stronger partner to its suppliers and customers. Nordic BioSite Group (NBG) is a leading European supplier of research and diagnostics products, with a particularly strong position within antibodies and other research […]

Cambridge, UK: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million (circa £30 million) investment round. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms.  Sphere Fluidics […]

Leaders in tech, biotech, and synthetic biology join to advance first commercial molecular electronics chip SAN DIEGO, Calif. — Roswell Biotechnologies, Inc., the molecular electronics company, announced today the formation of its Scientific Advisory Board (SAB). Comprised of industry and academic leaders in science and technology, the new SAB will be instrumental in the final […]

The new platform broadens Cellenion’s single cell dispensing solutions portfolio by enabling the isolation and handling of cellular aggregates from 80 µm to 600 µm including spheroids, organoids, and tumoroids Today, SCIENION & Cellenion, BICO companies, announced the launch of spheroONE, an innovative single large-particle sorter and dispenser which will revolutionize 3D cellular model handling. The platform is capable of […]

LUMICKS, a next generation life science tools company, today announced it has appointed Joshua Young to lead the company’s Investor Relations, Communications and Strategy functions. Young will report directly to Olivier Heyning, CEO of LUMICKS and will be based out of the Company’s United States headquarters in Boston, Massachusetts. Young brings nearly 25 years of […]

Today marks the early-bird release of the next-generation of CellCapTure (CCT) software. CCT 5.1 is the first of five exciting new products that Stratedigm will be launching by the end of 2022. CCT 5.1 now has even more functionality focusing on our built-in fully automated Uber Comp, optional Visual Protocol Designer (VPD), and A600 High Throughput Auto Sampler (HTAS). With […]

GSK adds antibody discovery workflow to current cell line development process EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that GlaxoSmithKline (NYSE: GSK) has purchased an additional Beacon™ Optofluidic system to expand its antibody therapeutics capacity. The new Beacon system will leverage Berkeley Lights’ Opto™ Plasma B […]